M
Michael Moriarty
Researcher at Mount Sinai St. Luke's and Mount Sinai Roosevelt
Publications - 29
Citations - 707
Michael Moriarty is an academic researcher from Mount Sinai St. Luke's and Mount Sinai Roosevelt. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 11, co-authored 27 publications receiving 604 citations. Previous affiliations of Michael Moriarty include Dublin City University & Royal College of Surgeons in Ireland.
Papers
More filters
Journal ArticleDOI
Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis
Colin Clarke,Stephen F. Madden,Padraig Doolan,Sinead T Aherne,Helena Joyce,Lorraine O'Driscoll,William M. Gallagher,Bryan T. Hennessy,Michael Moriarty,John Crown,Susan Kennedy,Martin Clynes +11 more
TL;DR: Weighted gene coexpression network analysis (WGCNA) is a powerful 'guilt-by-association'-based method to extract coexpressed groups of genes from large heterogeneous messenger RNA expression data sets and a cluster of genes was found to correlate with prognosis exclusively for basal-like breast cancer.
Journal ArticleDOI
2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins.
Paul Dowling,Lorraine O'Driscoll,Paula Meleady,Michael Henry,Shunil Roy,Jo Ballot,Michael Moriarty,John Crown,Martin Clynes +8 more
TL;DR: The data presented here demonstrate that high‐abundant protein removal combined with 2‐D DIGE is a powerful strategy for the discovery of potential biomarkers for lung cancer‐specific biomarkers.
Journal ArticleDOI
Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy
Pierre Thirion,Ola Holmberg,Ola Holmberg,Conor D Collins,Carmel O'Shea,Michael Moriarty,Maeve Pomeroy,Catriona O'Sullivan,Steve Buckney,John Armstrong +9 more
TL;DR: This study demonstrates the feasibility of the experimental radiotherapy schedule, however more data are needed to confirm its efficacy.
Journal ArticleDOI
Lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized study comparing 750-rad treatment with 2,000-rad treatment.
John G. Hanly,John G. Hanly,Jaythoon Hassan,Jaythoon Hassan,Michael Moriarty,Michael Moriarty,Ciaran Barry,Ciaran Barry,Jack Molony,Jack Molony,E. B. Casey,E. B. Casey,Alex Whelan,Alex Whelan,Conleth Feighery,Conleth Feighery,Barry Bresnihan +16 more
TL;DR: It is suggested that 750-rad lymphoid irradiation is as effective as, but less toxic than, that with 2,000 rads in the management of patients with intractable rheumatoid arthritis.
Journal ArticleDOI
ICORG 05-03: Prospective Randomized Non-Inferiority Phase 3 Trial Comparing Two Radiation Schedules in Malignant Spinal Cord Compression not Proceeding with Surgical Decompression
Pierre Thirion,Lydia O'Sullivan,A. Clayton-Lea,C. Small,O. McArdle,Paul J. Kelly,Imelda Parker,Joe M. O'Sullivan,D. Hacking,Conor D Collins,M. Pomeroy,Michael Moriarty +11 more